Drug makers come up with aggressive OTC sales plan

Published: 2008-01-11 07:00:00

Updated: 2008-01-11 07:00:00

The majority of local pharmaceutical firms set forth their business plans for 2008, largely characterized by aggressive OTC sales with all-out incentive plans, amid concerns over expected sluggish ethical sales under the possible influence of free trade agreements and a series of drug price cuts....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK